Genetics
Collapse Genetic Counseling in Gynecologic Oncology: What Advanced Practitioners Need to Know

The genetic predisposition to cancer and the advent of targeted therapy ushered in the growth of genetic testing and genetic counseling in oncology. Genetic counseling for germline mutations and for somatic mutations have both grown exponentially in the last decades. Leading oncologists and genetics stakeholders strongly recommend that qualified oncology providers conduct predictive genetic testing. It is therefore expected that advanced practitioners, who are on the forefront of oncology patient care, play a key role in genetic counseling by developing an expertise through advancing their education and practice. 

Continuing Education Language


 

In support of improving patient care, this activity has been planned and implemented by the Society of Gynecologic Oncology (SGO) and the Advanced Practitioner Society for hematology and Oncology (APSHO). Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  SGO designates this activity for a maximum of 1.5 AMA PRA Category 1 Credits , ANCC or 0.15 CEU for ACPE credits.

 

AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (AAPA)

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits, from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.5 hours of Category 1 credit for completing this activity.

Enduring activity: Start date: October 17, 2017; Expiration date October 16, 2018

Successful Completion:

For successful completion of the continuing education activity, participants must complete the post test with a passing score of 66% and an evaluation.  

For Pharmacists: 

Pharmacy Universal Activity Number: 0594-0000-17-004-H01-P (knowledge based activity).; 0.15 CEU.

The pharmacists must submit their NABP ePID and DOB to the provider by after completing the online post test and evaluation.

Target Audience

A continuing education activity or nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, oncology and hematology nurses, pharmacists and physicians. 

Financial Disclosures

All individuals in positions to control the content of this program (e.g., planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Society of Gynecologic Oncology identified and resolved all conflicts of interest through mechanisms included in the SGO’s Conflict of Interest Resolution Policy.

Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity.

Disclosures
FACULTY

Heather Hampel has received consulting fees/honoraria from Beijing Genomics, has equity interests/stock options and has served on the advisory board for Genome Medical, has served on the advisory board for Invitae, and has a financial relationship with Myriad Genetic Labs, Inc. 

Paula Anastasia has served on speakers bureaus for Clovis, Genentech, and Merck. 

Brianna Hoffner has served as a consultant for Abbott Laboratories, Lilly, and Merck.

Leigha Senter-Jamieson has received consulting fees/honoraria from AstraZeneca, Clovis, and MyGene Counsel; and has served on speakers bureaus for FORCE, LBBC, and AstraZeneca.

Society of Gynecologic Oncology

Teri Jordan, CAE, CMP, has nothing to disclose.

 

LEAD NURSE PLANNER

Dorothy Caputo, MA, BSN, RN, has nothing to disclose.

 

PLANNERS

Jeannine Coronna has nothing to disclose.
Claudine Kiffer has nothing to disclose.
Patricia McLafferty has nothing to disclose.

Larry Rosenberg has nothing to disclose.
Lynn Rubin has nothing to disclose.
Pamela Hallquist Viale, RN, MS, CNS, ANP, has nothing to disclose.
Annie Yueh has nothing to disclose.

 

 

 

 

 


 

 

 

 

 

This activity is supported with an educational grant by AstraZeneca.

 

 

 

Formats Available: On-Demand
Original Series Date: October 15, 2017
On-Demand Release Date: Available Now

Approved Credit:
  • ANCC: 1.50 hours Continuing Medical Education
  • AAPA: 1.50 hours Continuing Medical Education
  • ACCME: 1.50 hours Continuing Medical Education
  • ACPE: 0.15 hours CEU

  • Register &
    More InfoRegister & <br />More Info Genetic Counseling in Gynecologic Oncology: What Advanced Practitioners Need to Know
    Collapse Genetic Counseling, Testing and Treatment Decisions: A Moving Target

    As technology and knowledge continue to outpace our ability to realize clinical implementation, controversy and confusion over genetic counseling, testing and treatment recommendations in gynecologic oncology, specifically related to “who, how, and when”, are reaching a peak. Who is best suited to address various aspects of care, and how and when should this care most effectively be delivered? How can the cancer care team unite to overcome substantive barriers such as the inadequate reimbursement of genetic counselors under current Medicare guidelines, payer restrictions, cascade testing, and a greater involvement of genetic counselors throughout the entire process when appropriate? This live webinar will summarize the in-depth analysis and outcomes of the SGO Genetics Summit that took place July 27-28. Please sign on to Connect Ed to participate in this much-needed conversation.

    Formats Available: On-Demand, Live Webcast + Streaming
    Original Series Date: October 13, 2015
    Register &
    More InfoRegister & <br />More Info Genetic Counseling, Testing and Treatment Decisions: A Moving Target
    Collapse GENETICS TOOLKIT
    Formats Available: On-Demand
    Original Series Date: November 09, 2020
    Register &
    More InfoRegister & <br />More Info GENETICS TOOLKIT
    Collapse Genetics Webinar Series

    This lecture series covers basic roles of genetics, genetic testing and genetic counseling in hereditary breast and ovarian cancer (HBOC), hereditary uterine and colon cancer (Lynch), and integration of hereditary assessment into practice. The lecture includes editorial and best practice discussions with SGO members who have integrated the following successfully into practice:

    • Hereditary Cancer in a Gynecologic Oncologist Practice: Focus on Breast and Hereditary Cancer
    • In a Gynecologic Oncologist Practice: Focus on Uterine and Colon
    • Integrating Hereditary Cancer Assessment into Practice
    Formats Available: On-Demand
    Original Series Date: August 26, 2014
    On-Demand Release Date: Available Now
    Register &
    More InfoRegister & <br />More Info Genetics Webinar Series
    Collapse Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2)

    Please join us for the first webinar of our new series COCKTAIL- Contemporary Ovarian Cancer: Keys to Therapies and Integrated Learning

    This 5-part series will include 4 webinars, and a live "Lunch and Learn" session at the 2018 SGO Annual Meeting on Women's Cancer.  Topics covered include:

    • Implementation strategies for genetic testing
    • Differences in currently available testing platforms
    • How to integrate genetic counselors in an environment where these resources are less abundant.

    Accreditation:

    Joint Accreditation:

     In support of improving patient care, [Insert name of Joint Accredited Provider] is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

    This activity has not been submitted to ACPE for Pharmacists credit

    AMA Credit Designation Statement - Physicians

    This activity is approved for 1.5 AMA PRA Category 1 Credits.™.

    ANCC Credit Designation Statement- Nurses

    This CE activity is approved for 1.5 ANCC contact hours.

    PAs may claim a maximum of Category 1 credits (1.5) for completing this activity.  NCCPA accepts CAMA PRA Category 1 Credits™ from organizaitons accredited by ACCME or a recognized medical society. 

     

    Formats Available: On-Demand, Live Webcast + Streaming
    Original Series Date: January 23, 2018
    On-Demand Release Date: Available Now

    Approved Credit:
  • ACCME: 1.50 hours AMA PRA Category 1 Credit(s)

  • Register &
    More InfoRegister & <br />More Info Germline and somatic genetic evaluation in breast and ovarian cancer (Cocktail Part 2)